Denervation system and method around the subclavian artery
By targeting the subclavian snares for neuromodulation and ablation through percutaneous catheterization, the method addresses the invasive limitations of current treatments, effectively regulating sympathetic innervation to reduce arrhythmia and improve cardiac function.
Patent Information
- Application Number
- JP2024577266
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-12-06
- Filing Date
- 2023-06-29
- Publication Date
- 2025-07-10
AI Technical Summary
Current treatments for cardiac arrhythmias, such as atrial fibrillation and ventricular arrhythmias, are invasive, have significant side effects, and do not effectively address the underlying sympathetic nerve signaling that exacerbates these conditions, leading to recurrent arrhythmias and heart failure.
Targeting the subclavian snares around the subclavian arteries for selective neuromodulation and ablation using percutaneous catheterization, allowing precise regulation of sympathetic innervation to the heart, reducing cardiac electrical heterogeneity and alleviating pathological disease progression.
This approach provides a less invasive and more effective method to regulate sympathetic innervation, reducing arrhythmia burden and improving cardiac function by selectively ablating sympathetic nerves, thereby minimizing side effects and enhancing treatment efficacy.
Smart Images

Figure 2025521829000001_ABST